Lindsay Victoria, PhD

Highlights

1
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
LVLindsay Victoria LOLauren Oberlin IIIrena Ilieva AJAbhishek Jaywant+1 more →FGFaith Gunning
PMID: 39358543PMCID: PMC11631953DOIFirst author11 citations

6 grants

Co-I
JOSH-MH: Jointly Observed Scalable Hypotheses for Mental Health
National Institute of Mental Health · 2024–2029 · via The General Hospital Corporation (dba Massachusetts General Hospital)
U01MH136059-01
Co-I
Precision mapping and neuromodulation of fronto-striatal-limbic brain circuits to identify mood switch mechanisms in bipolar disorder
BD2 LLC · 2025–2028
TMI 250797-01
Co-I
An open-label trial of a novel prefrontal cortical interneuron-targeting antidepressant medication combination to achieve rapid antidepressant responses with minimal side effects
Hope for Depression Research Foundation · 2026–2028
HDRF 262807-01
Co-I
Efficacy of biomarker-guided rTMS for treatment resistant depression
National Institute of Mental Health · 2019–2027
R01MH118388-01
Co-I
Biomarker-Guided Antidepressant Selection for Treatment-Resistant Depression
National Institute of Mental Health · 2024–2026
UG3MH137656-01
PI
Prediction Error and Affective Salience Abnormalities in Aging and Late-Life Depression
National Institute of Mental Health · 2019–2025Career
K01MH118480-05

Completed grants (1)

Co-I
Modeling and Model Integration (Transition Funding)
Wellcome Leap, Inc. · 2024–2025 · via Vanderbilt University
UNIV61176

Completed & closed trials (1)

PI
Positive Valence System Function and Reward Exposure Therapy for Late-Life Depression
NA · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2024)
Major Depressive Disorder
NCT03688139